Xiaolin Xu

Xiaolin Xu

Auto-generated profile, based on publicly available information

Xiaolin Xu

Capital Medical University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
WZWenyue Zhang
Wenyue Zhang
XXXiaoyun Xiao
Xiaoyun Xiao
XXXiaolin Xu
Xiaolin Xu
MLMing Liang
Ming Liang
HWHuan Wu
Huan Wu
BLBaoming Luo
Baoming Luo

22 May 2010 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
RRRuojin Ren
Ruojin Ren
BLBin Li
Bin Li
FGFei Gao
Fei Gao
LLLiaoqing Li
Liaoqing Li
XXXiaolin Xu
Xiaolin Xu
JJJost B. Jonas
Jost B. Jonas

1 July 2021 in Eye
Verified
Journal Article
Closed access
PDF file
NZNan Zhou
Nan Zhou
XXXiaolin Xu
Xiaolin Xu
YLYueming Liu
Yueming Liu
YWYaxing Wang
Yaxing Wang
WWWenbin Wei
Wenbin Wei

18 August 2018 in International Journal of Ophthalmology
Verified
Journal Article
Open access
YWYing-Chih Wang
Ying-Chih Wang
XYXuan Yang
Xuan Yang
WWWenbin Wei
Wenbin Wei
XXXiao-Lin Xu
Xiao-Lin Xu
To reveal the insight mechanism of liver metastasis in uveal melanoma, we investigated cell functions of microRNA-21 in three different uveal melanoma cell lines and analyze the relationship of target gene p53 and its downstream targets. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to detect microRNA-21 expression in normal uveal tissue and uveal melanoma cell lines. Lenti-virus expression system was used to construct OCM-1, MuM-2B and M619 cell line with stable overexpression and inhibition of microRNA-21. In vitro cell function tests such as cell proliferation, cell apoptosis, cell circle and abilities of migration and invasion were examined by MTT, BrdU assay, flow cytometry, transwell assay and Matrigel invasion assay respectively. The target gene was predicted by bioinformatics and confirmed by using a dual luciferase reporter assay. The expression of p53 and its suspected downstream targets LIM and SH3 protein 1 (LASP1) and glutathione S transferase pi (GST-Pi) were determined by qRT-PCR in mRNA level and Western blotting analysis in protein level. Finally, the effect of microRNA-21 in a xenograft tumor model was assessed in four-week-old BALB/c nude mice. Compared to normal uveal melanoma, expressions of microRNA-21 were significantly higher in uveal melanoma cell lines. Overexpression of microRNA-21 promoted proliferation, migration, and invasion of OCM-1, M619 and MuM-2B cells, while inhibition of microRNA-21 reveal opposite effects. Wild type p53 was identified as a target gene of microRNA-21-3p, and proved by dual luciferase reporter assay. Up-regulated microRNA-21 inhibited the expression of wild type p53 gene, and the increased expression of LASP1 in mRNA level and protein level, while down-regulated microRNA-21 presented opposite way. However, GST-pi showed the potential pattern as expected, but relative mRNA level showed no statistically significant difference in OCM-1 cells. Furthermore, the mRNA expression of GST-pi was decreased in microRNA-21 overexpressing MuM-2B, and increased in M619 cells with inhibition of microRNA-21. In vivo, inhibition of microRNA-21 reduced tumor growth with statistically significant difference. These findings provide novel insight into molecular etiology of microRNA-21 in uveal melanoma cell lines, and suggest that microRNA-21 might be a potential candidate for the diagnosis and prognostic factor of human uveal melanoma.

18 July 2010 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
SBShuwei Bai
Shuwei Bai
RRRuojin Ren
Ruojin Ren
JSJitong Shi
Jitong Shi
XXXiaolin Xu
Xiaolin Xu
JZJunyang Zhao
Junyang Zhao
JJJost B. Jonas
Jost B. Jonas
Background To investigate the clinical and histopathological features of eyes enucleated due to retinoblastoma in a 50-year period in China. Methods The study included all eyes enucleated for retinoblastoma in the Beijing TongRen Hospital in the study period from 1957 to 2006. The clinical and histological charts, and histological slides were assessed for demographic and clinical data, and histological findings. Results The study included 1234 eyes. The mean age at the time of diagnosis (2.8±1.8 years) with a peak at 1 year of age decreased significantly (p<0.001) during the study period. Children with a unilateral retinoblastoma were significantly (p<0.001) older than children with bilateral retinoblastoma. The mean delay in the diagnosis (5.5±7.2 months) was significantly (p<0.0001) associated with the age at the time of diagnosis and significantly (p<0.0001) decreased during the study period. The presenting symptoms were leucocoria (67.2%), poor vision (10.8%), a detectable tumour mass (6.4%), red and painful eye (5.3%), strabismus (4.4%), exophathalmos (2.1%) and trauma (2.3%). Prevalence of an extraocular tumour extension decreased significantly (p<0.0001) during the study period. The frequency of a tumour invasion into the retro lamina cribrosa tissue or into the choroid decreased from 45.5% and 60.6% in the period 1956–1961 to 21.5% and 18.6%, respectively, in the period 2002–2006. Conclusions In the last 50 years, the diagnosis of retinoblastoma in China has been improved markedly with a shorter delay in the diagnosis, an overall earlier diagnosis and a decrease in the clinical and histological stage at the time of treatment.

2 January 2024 in Eye
Verified
Journal Article
Closed access
PDF file
LDLi Dong
Li Dong
XXXiao-Lin Xu
Xiao-Lin Xu
HLHe-Yan Li
He-Yan Li
QYQiong Yang
Qiong Yang
RZRui-Heng Zhang
Rui-Heng Zhang
YLYue-Ming Liu
Yue-Ming Liu